Clinical decision-support only. For use by licensed dental professionals. Not a substitute for professional judgment or a complete drug reference. Always verify with primary sources.
← Back to search
Condition

Sickle cell disease

Hematologic

Likelihood of oral impactHigh

How likely this condition is to affect the mouth.

Evidence confidenceModerate

Strength of the peer-reviewed evidence.

Oral health effects

  • Nerve death in healthy-looking teeth (aseptic pulpal necrosis)

    Patients with SCD can develop pulpal necrosis in clinically intact, caries-free teeth with no other odontogenic cause.

    Mechanism: Vaso-occlusive crises in the dental pulp's microcirculation cause ischemic pulp tissue death.

    Clinical management: Consider SCD in the differential for a nonvital tooth with no caries, trauma, or restorative history; manage per standard endodontic protocol.

  • Thin or poorly formed enamel (enamel and dentin hypoplasia)

    Developmental enamel (and sometimes dentin) hypoplasia is more common in SCD patients and increases susceptibility to dental caries.

    Mechanism: Chronic anemia and hypoxia during odontogenesis are thought to disrupt normal enamel/dentin formation.

    Clinical management: Reinforce caries-preventive measures (fluoride, sealants, diet counseling) and monitor hypoplastic sites closely.

  • Pale or yellow-tinged mouth lining (mucosal pallor / jaundice)

    Pallor of the buccal and labial mucosa and gingiva, sometimes with jaundice, is the most commonly reported intraoral finding in SCD.

    Mechanism: Chronic hemolytic anemia and hyperbilirubinemia.

    Clinical management: Recognize as a diagnostic clue rather than a disease requiring dental intervention; correlate with medical history.

  • Jawbone infection and jaw pain (mandibular/maxillary osteomyelitis)

    Documented cases of mandibular osteomyelitis and jaw bone pain occur in SCD, sometimes mimicking odontogenic infection.

    Mechanism: Vaso-occlusion and infarction of jaw bone marrow create ischemic tissue vulnerable to secondary bacterial infection.

    Clinical management: Distinguish bony vaso-occlusive pain from odontogenic infection with imaging/labs before intervening surgically; treat true infection aggressively with antimicrobials.

  • Numb lower lip and chin (mental nerve paresthesia)

    Vaso-occlusion within the inferior alveolar/mental nerve canal can cause numbness of the lower lip and chin that may persist for up to roughly 24 months.

    Mechanism: Ischemic injury to the mental/inferior alveolar nerve from vaso-occlusion in the mandibular canal.

    Clinical management: Document baseline lip/chin sensation before invasive mandibular procedures; if new paresthesia arises with no clear procedural cause, consider a sickle-related etiology and involve the patient's hematologist.

Sources

  1. Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review. Kakkar M, Holderle K, Sheth M, Arany S, Schiff L, Planerova A. Anemia, 2021.
  2. Oral manifestations of sickle cell disease and its effects on dental and periodontal health: A systematic review. Guirassy ML, Baglo FE, Diallo AM, Mbow NL, Thiam D, Seck-Diallo A, Benoist HM. Journal of Advanced Periodontology & Implant Dentistry, 2025.